Tenax Therapeutics, Inc. (TENX) Financial Statements (2024 and earlier)

Company Profile

Business Address 101 GLEN LENNOX DRIVE
CHAPEL HILL, NC 27517
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,123,6825,583,9226,712,9285,399,87712,861,9547,727,210
Cash and cash equivalents2,123,6825,583,9226,250,2414,905,99312,367,3211,604,810
Short-term investments   462,687493,884494,6336,122,400
Receivables      50,171
Prepaid expense738,927105,07882,578780,952458,286285,512
Other current assets345,856     
Other undisclosed current assets      
Total current assets:3,208,4655,689,0006,795,5066,180,82913,320,2408,062,893
Noncurrent Assets
Operating lease, right-of-use asset 179,503287,69258,778169,448
Property, plant and equipment 7,1897,1085,9726,5598,5259,945
Long-term investments and receivables      1,809,428
Long-term investments      1,809,428
Other noncurrent assets9,5528,4358,4358,4358,4358,435
Total noncurrent assets:196,244303,23573,185184,44216,9601,827,808
TOTAL ASSETS:3,404,7095,992,2356,868,6916,365,27113,337,2009,890,701
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,223,4701,563,9781,998,4722,532,3951,565,669975,167
Accounts payable448,425859,638757,8561,661,054749,814611,861
Accrued liabilities775,045704,3401,240,616871,341815,855363,306
Other undisclosed accounts payable and accrued liabilities      
Debt624,302 120,491   
Other undisclosed current liabilities     33,673
Total current liabilities:1,847,7721,563,9782,118,9632,532,3951,565,6691,008,840
Noncurrent Liabilities
Long-term debt and lease obligation  183,589124,16660,379  
Long-term debt, excluding current maturities   124,166   
Liabilities, other than long-term debt 64,196     
Operating lease, liability 64,196183,589 60,379
Other undisclosed noncurrent liabilities  (183,589)    
Total noncurrent liabilities: 64,196183,589124,16660,379  
Total liabilities:1,911,9681,747,5672,243,1292,592,7741,565,6691,008,840
Equity
Equity, attributable to parent, including:1,492,7414,244,6684,625,5623,772,49711,771,5318,881,861
Preferred stock  2,521    
Common stock4,584 1,262674379141
Additional paid in capital291,030,237282,736,332250,644,197239,939,797239,572,094222,397,198
Accumulated other comprehensive income (loss)   (70)458516(16,193)
Accumulated deficit(289,542,080)(278,494,185)(246,019,827)(236,168,436)(227,801,743)(213,499,285)
Other undisclosed equity, attributable to parent    4285 
Total equity:1,492,7414,244,6684,625,5623,772,49711,771,5318,881,861
TOTAL LIABILITIES AND EQUITY:3,404,7095,992,2356,868,6916,365,27113,337,2009,890,701

Income Statement (P&L) (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(11,052,643)(32,728,241)(9,867,930)(8,555,264)(6,893,280)(9,205,898)
Other operating expense, net  (254,832)    
Other undisclosed operating income 65,711,314    
Operating income (loss):(11,052,643)32,728,241(9,867,930)(8,555,264)(6,893,280)(9,205,898)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
9,191 18,166160,90179,835366,216
Interest and debt expense(4,443)247,233(1,627)   
Income (loss) from continuing operations:(11,047,895)32,975,474(9,851,391)(8,394,363)(6,813,445)(8,839,682)
Income (loss) before gain (loss) on sale of properties:32,975,474(9,851,391)(8,394,363)(6,813,445)(8,839,682)
Other undisclosed net loss (501,116)    
Net income (loss):(11,047,895)32,474,358(9,851,391)(8,394,363)(6,813,445)(8,839,682)
Other undisclosed net income (loss) attributable to parent (64,948,716)  (7,330,604) 
Net income (loss) available to common stockholders, diluted:(11,047,895)(32,474,358)(9,851,391)(8,394,363)(14,144,049)(8,839,682)

Comprehensive Income (USD)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(11,047,895)32,474,358(9,851,391)(8,394,363)(6,813,445)(8,839,682)
Comprehensive income (loss):(11,047,895)32,474,358(9,851,391)(8,394,363)(6,813,445)(8,839,682)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (70)19,703,31016,788,78420,940,78517,676,839
Comprehensive income (loss), net of tax, attributable to parent:(11,047,895)32,474,2889,851,9198,394,42114,127,3408,837,157

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: